Federal Circuit Affirms Findings That 2 Claims Of 2 Patents Are Invalid
WASHINGTON, D.C. — A New Jersey federal judge did not err in holding that two patents relating to oral dosage forms of risedronate and disodium ethylenediaminetetraacetic acid (EDTA) are invalid as...To view the full article, register now.
Already a subscriber? Click here to view full article